The “List of Policies for Pharmacovigilance” provides a comprehensive framework for monitoring, assessing, and managing the safety of pharmaceutical products throughout their lifecycle. These policies help healthcare and pharmaceutical organizations ensure patient safety, regulatory compliance, and effective risk management related to medicinal products. The collection typically includes policies related to adverse event reporting, signal detection, risk evaluation, safety data management, case processing, product safety monitoring, regulatory submissions, medical review, and safety communication. It also covers areas such as pharmacovigilance audits, vendor oversight, data privacy, quality assurance, literature monitoring, training, business continuity, and compliance with global health authority requirements. Implementing well-defined pharmacovigilance policies enables organizations to identify and mitigate drug-related risks, maintain accurate safety records, improve regulatory reporting, and strengthen public trust in healthcare products. These documents serve as operational guidelines for pharmacovigilance teams, medical affairs professionals, regulatory personnel, clinical researchers, and healthcare organizations involved in drug safety management.  
  

1. P109-01 Pharmacovigilance Governance Policy
2. P109-02 Adverse Event Reporting Policy
3. P109-03 Serious Adverse Event Management Policy
4. P109-04 Signal Detection and Management Policy
5. P109-05 Risk Management Policy
6. P109-06 Safety Data Collection Policy
7. P109-07 Individual Case Safety Report Processing Policy
8. P109-08 Product Safety Monitoring Policy
9. P109-09 Regulatory Reporting Policy
10. P109-10 Periodic Safety Update Report Policy
11. P109-11 Benefit-Risk Assessment Policy
12. P109-12 Medical Review Policy
13. P109-13 Literature Monitoring Policy
14. P109-14 Safety Database Management Policy
15. P109-15 Pharmacovigilance Audit Policy
16. P109-16 Quality Assurance in Pharmacovigilance Policy
17. P109-17 Pharmacovigilance Training Policy
18. P109-18 Vendor Oversight Policy
19. P109-19 Data Privacy and Confidentiality Policy
20. P109-20 Case Intake and Triage Policy
21. P109-21 Product Complaint Handling Policy
22. P109-22 Medication Error Reporting Policy
23. P109-23 Pregnancy Exposure Reporting Policy
24. P109-24 Safety Communication Policy
25. P109-25 Regulatory Inspection Readiness Policy
26. P109-26 Pharmacovigilance Documentation Policy
27. P109-27 Record Retention and Archiving Policy
28. P109-28 Global Safety Compliance Policy
29. P109-29 Clinical Trial Safety Reporting Policy
30. P109-30 Post-Marketing Surveillance Policy
31. P109-31 Signal Escalation Policy
32. P109-32 Corrective and Preventive Action Policy
33. P109-33 Pharmacovigilance System Master File Policy
34. P109-34 Third-Party Service Provider Policy
35. P109-35 Information Security Policy
36. P109-36 Business Continuity Policy
37. P109-37 Safety Labeling Update Policy
38. P109-38 Risk Minimization Measures Policy
39. P109-39 Pharmacovigilance Compliance Monitoring Policy
40. P109-40 Digital Safety Reporting Policy
41. P109-41 Social Media Monitoring Policy
42. P109-42 Patient Support Program Safety Policy
43. P109-43 Healthcare Professional Communication Policy
44. P109-44 Aggregate Reporting Policy
45. P109-45 Safety Metrics and Reporting Policy
46. P109-46 Escalation and Crisis Management Policy
47. P109-47 Pharmacovigilance Inspection Management Policy
48. P109-48 Global Safety Data Exchange Policy
49. P109-49 Continuous Improvement in Pharmacovigilance Policy
50. P109-50 Pharmacovigilance Governance Review Policy